G. E. Mattingly

Suggest Changes
Learn More
OBJECTIVE To evaluate the long-term safety and effectiveness of lisdexamfetamine dimesylate (LDX) in the treatment of adults with attention-deficit/hyperactivity disorder (ADHD). METHODS Following(More)
OBJECTIVE To describe secondary analyses from a 12-week, randomized, open-label trial where adult schizophrenia outpatients receiving risperidone, olanzapine, or aripiprazole were switched to(More)
  • 1